E2F and histone deacetylase mediate transforming growth factor β repression of cdc25A during keratinocyte cell cycle arrest

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 916-922

  Iavarone, Antonio ^a,c   Massagué, Joan ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; HISTONE DEACETYLASE; TRANSCRIPTION FACTOR E2F; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032933352     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.1.916     Document Type: Article

References (47)

1. Alexandrow, M. G., and H. L. Moses. 1995. Transforming growth factor beta and cell cycle regulation. Cancer Res. 55:1452-1457.
2. Attisano, L., J. Cárcamo, F. Ventura, F. M. B. Weis, J. Massagué, and J. L. Wrana. 1993. Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671-680.
3. Beijersbergen, R., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:2680-2690.
4. Boukamp, P., R. T. Petrussevska, V. Breitkreutz, J. Harnung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
5. Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
6. Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355:176-179.
7. Carneiro, C., C. V. Alvarez, J. Zalvide, A. Vidal, and F. Dominguez. 1998. TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth. Oncogene 16:1455-1465.
8. Corbeil, H. B., and P. E. Branton. 1997. Characterization of an E2F-p130 complex formed during growth arrest. Oncogene 15:657-668.
9. Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X.-F. Wang. 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92: 5545-5549.
10. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
11. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
12. Elbendary, A., A. Berchuck, P. Davis, L. Havrilesky, J. R. C. Bast, J. D. Iglehart, and J. R. Marks. 1994. Transforming growth factor b1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5:1301-1307.
13. Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020.
14. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517.
15. Hannon, G. J., and D. Beach. 1994. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257-261.
16. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
17. Huet, X., J. Rech, A. Plet, A. Vié, and J. M. Blanchard. 1996. Cyclin A expression is under negative transcriptional control during the cell cycle. Mol. Cell. Biol. 16:3789-3798.
18. Hurford, R. K., D. Cobrinik, M.-H. Lee, and N. Dyson. 1997. pRB and p107/130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1447-1463.
19. Iavarone, A., and J. Massagué. 1997. Repression of the Cdk activator Cdc25A and cell-cycle arrest by cytokine TGFbeta in cells lacking the Cdk inhibitor p15. Nature 387:417-422.
20. Jinno, S., K. Suto, A. Nagata, M. Igarashi, Y. Kanaoka, H. Nojima, and H. Okayama. 1994. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13:1549-1556.
21. Kaelin, W. G., Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingslon, and E. K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351-364.
22. Laherty, C. D., W.-M. Yang, J.-M. Sun, J. R. Davie, E. Seto, and R. N. Eisenman. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349-356.
23. Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massagué. 1990. Growth inhibition by TGF-β1 linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185.
24. Li, J. M., P. P. Hu, X. Shea, Y. Yu, and X.-F. Wang. 1997. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites. Proc. Natl. Acad. Sci. USA 94:4948-4953.
25. Luo, R. X., A. A. Postigo, and D. C. Dean. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
26. Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605.
27. Malliri, A., W. A. Yeudall, M. Nikolic, D. H. Crouch, E. K. Parkinson, and B. Ozanne. 1996. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events. Cell Growth Differ. 7:1291-1304.
28. Massagué, J. 1990. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6:597-641.
29. Moberg, K., M. A. Starz, and J. A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436-1449.
30. Moses, H. L., E. Y. Yang, and J. Pietenpol. 1990. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247.
31. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yacuik, R. Schlegel, R. M. Lyons, R. M. Pittelkow, K. Münger, P. M. Howley, and H. L. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming protein with pRB binding domains. Cell 61:777-785.
32. Reynisdóttir, I., K. Polyak, A. Iavarone, and J. Massagué. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831-1845.
33. INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell Biol. 17:2458-2467.
34. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
35. Taunton, J., C. A. Hassig, and S. L. Schreiber. 1996. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272:408-411.
36. Tommasi, S., and G. P. Pfeifer. 1995. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol. 15:6901-6913.
37. Vairo, G., D. M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869-881.
38. Verona, R., K. Moberg, S. Estes, M. Statz, J. P. Vernon, and J. A. Lees. 1997. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell. Biol. 17:7268-7282.
39. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
40. Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259-261.
41. Wieser, R., J. L. Wrana, and J. Massagué. 1995. GS domain mutations that constitutively activate TβRI, the downstream signaling component in the TGFβ receptor complex. EMBO J. 14:2199-2208.
42. Wolffe, A. P. 1996. Histone deacetylase: a regulator of transcription. Science 272:371-372.
43. Wolffe, A. P. 1997. Sinful repression. Nature 387:16-17.
44. Yoshida, M., S. Horinouchi, and T. Beppu. 1995. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17:423-430.
45. Zwicker, J., N. Liu, K. Engeland, F. C. Lucibello, and R. Muller. 1996. Cell cycle regulation of E2F site occupation in vivo. Science 271:1595-1597.
46. Zwicker, J., F. C. Lucibello, L. A. Wolfraim, C. Gross, M. Truss, K. Engeland, and R. Muller. 1995. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J. 14:4514-4522.
47. Zwicker, J., and R. Muller. 1997. Cell-cycle regulation of gene expression by transcriptional repression. Trends Genet. 13:3-6.